Literature DB >> 7580238

Abnormal expression of intermediate filament proteins in X-linked myotubular myopathy is not reproduced in vitro.

P F Van der Ven1, P H Jap, P G Barth, R C Sengers, F C Ramaekers, A M Stadhouders.   

Abstract

Expression patterns of the intermediate filament proteins (IFPs) desmin and vimentin, in biopsy material taken from a 1 day old boy with fatal neonatal X-linked myotubular myopathy (XLMTM) were compared with the expression of these proteins in cultured myotubes, from the same patient. Immunohistochemical studies revealed the persistence of high levels of desmin in virtually all, and vimentin in most, of the myofibres within the patient's biopsy. Analysis of intermediate filament expression in differentiating, cultured muscle cells did not reveal overt differences between XLMTM cultures and cultures of control muscle. Titin distribution patterns indicated a normal process of myofibrillogenesis in XLMTM myotubes. We conclude that the failure to properly regulate IFP-expression is not intrinsic to XLMTM muscle fibres. The possibility that this failure is due to a defective external, possibly neural factor, is discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7580238     DOI: 10.1016/0960-8966(94)00067-j

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  2 in total

1.  Myotubularin-deficient myoblasts display increased apoptosis, delayed proliferation, and poor cell engraftment.

Authors:  Michael W Lawlor; Matthew S Alexander; Marissa G Viola; Hui Meng; Romain Joubert; Vandana Gupta; Norio Motohashi; Richard A Manfready; Cynthia P Hsu; Ping Huang; Anna Buj-Bello; Louis M Kunkel; Alan H Beggs; Emanuela Gussoni
Journal:  Am J Pathol       Date:  2012-07-27       Impact factor: 4.307

2.  The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice.

Authors:  Anna Buj-Bello; Vincent Laugel; Nadia Messaddeq; Hala Zahreddine; Jocelyn Laporte; Jean-Francois Pellissier; Jean-Louis Mandel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.